VANNOZZI, LORENZO
 Distribuzione geografica
Continente #
NA - Nord America 1.837
EU - Europa 1.405
AS - Asia 368
AF - Africa 8
SA - Sud America 2
Totale 3.620
Nazione #
US - Stati Uniti d'America 1.828
RU - Federazione Russa 670
IT - Italia 209
IE - Irlanda 158
SE - Svezia 126
SG - Singapore 103
CN - Cina 77
PL - Polonia 77
HK - Hong Kong 73
JO - Giordania 66
CH - Svizzera 59
DE - Germania 36
IN - India 34
GB - Regno Unito 23
UA - Ucraina 16
FI - Finlandia 10
CA - Canada 9
AT - Austria 7
FR - Francia 6
TR - Turchia 6
VN - Vietnam 6
CI - Costa d'Avorio 5
ES - Italia 5
KR - Corea 3
AO - Angola 2
BE - Belgio 2
BR - Brasile 2
MU - Mauritius 1
NL - Olanda 1
Totale 3.620
Città #
Santa Clara 328
Fairfield 239
Dublin 158
Chandler 116
Ashburn 114
Woodbridge 109
Houston 98
Singapore 87
Warsaw 76
Cambridge 73
Seattle 71
Wilmington 68
Lawrence 61
Bern 58
Altamura 50
Hong Kong 44
Princeton 39
Moscow 38
Boston 32
Mumbai 29
Florence 27
Boardman 26
Shanghai 24
Ann Arbor 23
Beijing 19
Buffalo 19
Jacksonville 15
Medford 14
San Diego 14
Kent 13
New York 12
Milan 10
Rome 10
Falls Church 9
Yubileyny 8
Redwood City 7
Bologna 6
Dong Ket 6
Norwalk 6
Vienna 6
Abidjan 5
Aversa 5
Hillsboro 5
London 5
Los Angeles 5
Prato 5
Toronto 5
Barcelona 4
Cagliari 4
Castelfranco di Sotto 4
Guangzhou 4
Montréal 4
Altidona 3
Helsinki 3
Islington 3
Izmir 3
Somerville 3
Strada in Chianti 3
Taizhou 3
Adana 2
Atlanta 2
Bari 2
Brussels 2
Castelliri 2
Chennai 2
Desio 2
Lappeenranta 2
Leawood 2
Luanda 2
Montespertoli 2
Munich 2
New Bedfont 2
Seoul 2
Stezzano 2
Stockholm 2
São Paulo 2
Washington 2
Wernigerode 2
Aci Catena 1
Agordo 1
Andover 1
Asti 1
Auburn Hills 1
Bethesda 1
Buggiano 1
Changsha 1
Chieti 1
Chiswick 1
Corciano 1
Dalmine 1
Desenzano Del Garda 1
Esslingen am Neckar 1
Frankfurt Am Main 1
Gabicce Mare 1
Gandhi Nagar 1
Hangzhou 1
Hounslow 1
Incisa 1
Irkutsk 1
Kilburn 1
Totale 2.298
Nome #
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 163
Bilateral choroidal metastasis from adenoid cystic carcinoma of the submandibular salivary gland 139
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 139
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: a four-year follow-up study 130
Clear corneal incision of 2.75 mm for cataract surgery induces little change of astigmatism in eyes with low preoperative corneal cylinder 128
Bevacizumab (Avastin®) nel trattamento della neovascolarizzazione coroideale miopica 126
CFH Y402H polymorphism in Italian patients with age-related macular degeneration, retinitis pigmentosa, and Stargardt disease 123
Long-term survival in metastatic melanoma patients treated with sequential biochemotherapy: report of a Phase II study. 119
Vitrectomy for vitreous opacities and macular pucker in Gaucher disease 114
Morpho-Functional Evaluation of Full-Thickness Macular Holes by the Integration of Optical Coherence Tomography Angiography and Microperimetry 110
Cytomegalovirus retinitis following intravitreal dexamethasone implant in a patient with central retinal vein occlusion 104
New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy 95
I farmaci biologici 91
Ocular safety of infliximab in rabbit and cell culture models 88
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 88
Long-term Retention Rates of Adalimumab and Infliximab in Non-Infectious Intermediate, Posterior, and Panuveitis 87
Predictors of Sustained Clinical Response in Patients With Behçet's Disease-Related Uveitis Treated With Infliximab and Adalimumab 86
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 83
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 83
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 82
FRI0586 Interleukin (IL)-1 inhibition with anakinra and canakinumab in behÇet's disease related uveitis: a multicenter retrospective observational study 80
THU0540 Efficacy and safety of adalimumab in behÇet's disease related uveitis: a multicenter retrospective observational study 79
Retinal capillaritis in a CRB1-associated retinal dystrophy 78
Macular hole in Stargardt disease: Clinical and ultra-structural observation 77
Behçet’s syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics 75
The role of OCT angiography in the assessment of epiretinal macular membrane 75
Evaluation of intraoperative slow-release dexamethasone implant combined with idiopathic epiretinal membrane removal 74
Non-anti TNFα biologic agents for noninfectious uveitis associated with systemic inflammatory diseases: a systematic review 70
Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis 70
Efficacy of anti-tumour necrosis factor-α monoclonal antibodies in patients with non-infectious anterior uveitis 69
Efficacy and safety of adalimumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study 68
The role of anterior segment optical coherence tomography in uveitis-glaucoma-hyphema syndrome 68
Efficacy of monoclonal anti-tumour necrosis factor-α antibodies in uveitic macular oedema 66
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study 65
Vitreoschisis and retinal detachment: New insight in proliferative vitreoretinopathy 64
Low-dose tocilizumab for relapsing giant cell arteritis in the elderly, fragile patient: Beyond the GiACTA trial 56
The protean ocular involvement in monogenic autoinflammatory diseases: state of the art 55
Treating the Different Phenotypes of Behçet's Syndrome 54
The Role of Biosimilars in Uveitis: Long-Term Real-World Outcomes of the Switch From Original to Biosimilar TNF-Alpha Inhibitors 49
Enhancing Intermediate Vision in Patients Affected by Epiretinal Membrane Treated by Phaco-Vitrectomy 48
Case report: 3D intracranial vessel wall MRI in Susac syndrome: potential relevance for diagnosis and therapeutic management 46
Intravitreal Dexamethasone Implant as an Adjunct Weapon for Severe and Refractory Uveitis in Behçet's Disease 43
Adaptive Optics Imaging to Analyze the Photoreceptor Layer Reconstitution in Acute Syphilitic Posterior Placoid Chorioretinopathy 42
Optical coherence tomography angiography findings in patients affected by giant cell arteritis, with and without ocular involvement: a pilot study 32
Totale 3.681
Categoria #
all - tutte 12.542
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.542


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020272 0 0 0 0 37 40 32 36 37 23 28 39
2020/2021416 32 29 30 32 45 36 89 21 33 29 14 26
2021/2022278 4 11 20 9 4 18 1 34 11 9 41 116
2022/2023819 69 174 40 19 28 125 93 39 113 5 47 67
2023/2024365 8 33 49 20 24 34 17 73 26 29 25 27
2024/20251.267 87 230 148 394 408 0 0 0 0 0 0 0
Totale 3.681